IP Library › Granted Patent US 7,634,315
Granted Patent B2
US 7,634,315 · App. 11/756,527 · Granted Dec 15, 2009

Techniques to monitor and trend nerve damage and recovery

Assignee: Pacesetter, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,634,315
App. No.
11/756,527
Granted
Dec 15, 2009
Kind
B2
Abstract

An exemplary method includes implementing a nerve stimulation therapy that includes delivering stimulation energy to a target nerve, periodically acquiring compound action potentials responsive to the delivered stimulation energy and assessing condition of the target nerve based at least in part on the periodically acquired compound action potentials. Various other exemplary methods, devices, systems, etc., are also disclosed.

Claims (26)

1. A method comprising:

implementing a nerve stimulation therapy within the body that comprises delivering therapeutic stimulation energy to a target nerve;

temporarily halting the delivering therapeutic stimulation energy to the target nerve;

during the halting, delivering diagnostic stimulation energy to the target nerve;

acquiring a compound action potential responsive to the delivered non-therapeutic stimulation energy;

recommencing the delivering therapeutic stimulation energy to the target nerve; and

assessing condition of the target nerve based at least in part on the acquired compound action potential.

2. The method of claim 1 wherein the target nerve comprises a vagal nerve.

3. The method of claim 1 wherein the nerve stimulation therapy treats epilepsy by delivering therapeutic stimulation energy to a vagal nerve.

4. The method of claim 1 wherein the nerve stimulation therapy treats obesity by delivering therapeutic stimulation energy to a vagal nerve.

5. The method of claim 1 wherein the nerve stimulation therapy treats sleep apnea by delivering therapeutic stimulation energy to a phrenic nerve.

6. The method of claim 1 wherein the assessing comprises determining if condition of the target nerve is worsening or improving.

7. A method comprising:

implementing a nerve stimulation therapy within the body that comprises delivering stimulation energy to a target nerve;

periodically acquiring compound action potentials responsive to the delivered stimulation energy; and

assessing condition of the target nerve based at least in part on the periodically acquired compound action potentials.

8. The method of claim 7 wherein the acquiring acquires a compound action potential responsive to every delivery of stimulation energy.

9. The method of claim 7 wherein the target nerve comprises a vagal nerve.

10. The method of claim 7 wherein the nerve stimulation therapy treats epilepsy by delivering therapeutic stimulation energy to a vagal nerve.

11. The method of claim 7 wherein the nerve stimulation therapy treats obesity by delivering therapeutic stimulation energy to a vagal nerve.

12. The method of claim 7 wherein the nerve stimulation therapy treats sleep apnea by delivering therapeutic stimulation energy to a phrenic nerve.

13. The method of claim 7 wherein the assessing comprises determining if condition of the target nerve is worsening or improving.

14. An implantable medical device comprising:

means for delivering stimulation energy to a target nerve;

means for acquiring compound action potentials responsive to the delivered stimulation energy; and

means for assessing a condition of the target nerve based at least in part on the compound action potentials.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2007
From: CHOLETTE, MARTIN
To: PACESETTER, INC.
Reel/Frame 019363/0573 →
Continuity (1)
Related Publication 20080300655A1 · Dec 4, 2008